Lumos Pharma, Inc. (LUMO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Lumos Pharma, Inc. faces a significant risk ...

Our new leadership team continues to author a new future for Pineapple Energy, with a focus on elevating our corporate governance, properly aligning our cost structure, creating a new corporate ...

The contingent value right (CVR) offered by BMS as a sweetener for the $74 billion takeover of Celgene in 2019 is defunct, as one of the three drugs – CAR-T therapy liso-cel for lymphoma ...

Pineapple Energy (PEGY) will distribute to the holders of its non-transferable Contingent Value Rights a payment of $850,269, or $0.35 per CVR.

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Total revenue for the fiscal third quarter of 2024 was $95.4 million, and consisted of $68.1 million in Digital asset ...

“We intend the Rights Plan to enable all of our stockholders to realize the long-term value of their investment. The Rights Plan should reduce the likelihood that any person or group gains ...

Welcome to the Contingent Election, another quirky land mine in our sacred Constitution, a charming document that takes for granted in its charming naivete that we all will not go insane at ...

A Brazilian state that straddles the frontier of the Amazon jungle is pursuing the sale of more than 2.5 billion reais ($430.16 million) in carbon credits related to forest conservation through 2030, ...

AUSTIN, Texas–(BUSINESS WIRE)–$CORZ #aicloud—Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for bitcoin mining and HPC, today ...